Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- CheckyesterdayChange DetectedA banner notice says NIH is transitioning to using “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) and directs visitors to updates and FAQs.SummaryDifference0.5%

- Check8 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed, indicating the record has been updated.SummaryDifference0.1%

- Check56 days agoChange DetectedThe history now shows a new revision tag 'Revision: v3.6.6' added to the history, replacing the previous 'Revision: v3.6.5'. This indicates an update to the study record's revision history.SummaryDifference0.1%

- Check78 days agoChange DetectedA new Revision: v3.6.5 entry was added to the record history, indicating the study record history has been updated. The update is metadata about versioning rather than a modification to the study data.SummaryDifference12%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.